Literature DB >> 28196617

The neuropeptides Galanin and Galanin(1-15) in depression-like behaviours.

Carmelo Millón1, Antonio Flores-Burgess2, Manuel Narváez2, Dasiel O Borroto-Escuela3, Belén Gago2, Luis Santín4, Estela Castilla-Ortega4, José Ángel Narváez2, Kjell Fuxe3, Zaida Díaz-Cabiale2.   

Abstract

Galanin is a 29 amino acid neuropeptide widely distributed in neurons within the central nervous system. Galanin exerts its biological activities through three different G protein-receptors and participates in a number of functions, including mood regulation. Not only Galanin but also Galanin N-terminal fragments like Galanin(1-15) are active at the central level. In this work, we review the latest findings in studies on Galanin and Galanin(1-15) in depression-related behaviours. Our focus is on animal models for depression, and we pay some attention to research data obtained in human studies. Since Serotonin (5-HT), especially through 5-HT1A, and Galanin receptors interact at both pre-and postsynaptic level, the development of drugs targeting potential GAL1-GAL2-5-HT1A heteroreceptor complexes linked to the raphe-hippocampal 5-HT neurons may represent new treatment strategies in depression.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Depression; Galanin

Mesh:

Substances:

Year:  2017        PMID: 28196617     DOI: 10.1016/j.npep.2017.01.004

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  9 in total

1.  An assembly of galanin-galanin receptor signaling network.

Authors:  Lathika Gopalakrishnan; Oishi Chatterjee; Chinmayi Raj; Deepshika Pullimamidi; Jayshree Advani; Anita Mahadevan; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2020-11-02       Impact factor: 5.782

2.  Effect of depression and suicidal behavior on neuropeptide Y (NPY) and its receptors in the adult human brain: A postmortem study.

Authors:  Anuradha Sharma; Xinguo Ren; Hui Zhang; Ghanshyam N Pandey
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-08-17       Impact factor: 5.067

Review 3.  Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders.

Authors:  Miguel Pérez de la Mora; Dasiel O Borroto-Escuela; Minerva Crespo-Ramírez; José Del Carmen Rejón-Orantes; Daniel Alejandro Palacios-Lagunas; Magda K Martínez-Mata; Daniela Sánchez-Luna; Emiliano Tesoro-Cruz; Kjell Fuxe
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

Review 4.  Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines.

Authors:  Mervin Chávez-Castillo; Victoria Núñez; Manuel Nava; Ángel Ortega; Milagros Rojas; Valmore Bermúdez; Joselyn Rojas-Quintero
Journal:  Adv Pharmacol Sci       Date:  2019-01-03

5.  The Combination of Galanin (1-15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression.

Authors:  Noelia Cantero-García; Antonio Flores-Burgess; David Ladrón de Guevara-Miranda; Antonia Serrano; Laura García-Durán; Araceli Puigcerver; Kjell Fuxe; José Ángel Narváez; Luis Javier Santín; Zaida Díaz-Cabiale; Carmelo Millón
Journal:  Biomedicines       Date:  2022-02-09

6.  Galanin Regulates Myocardial Mitochondrial ROS Homeostasis and Hypertrophic Remodeling Through GalR2.

Authors:  Frederic Boal; Mathieu Cinato; Andrei Timotin; Heike Münzberg; Emily Qualls-Creekmore; Solomiia Kramar; Halyna Loi; Jerome Roncalli; Sokhna Keita; Helene Tronchere; Oksana Kunduzova
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

7.  Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression.

Authors:  Antonio Flores-Burgess; Carmelo Millón; Belen Gago; Laura García-Durán; Noelia Cantero-García; Araceli Puigcerver; José Angel Narváez; Kjell Fuxe; Luis Santín; Zaida Díaz-Cabiale
Journal:  Int J Neuropsychopharmacol       Date:  2022-04-19       Impact factor: 5.678

Review 8.  The Galaninergic System: A Target for Cancer Treatment.

Authors:  Manuel Lisardo Sánchez; Rafael Coveñas
Journal:  Cancers (Basel)       Date:  2022-08-01       Impact factor: 6.575

Review 9.  Anxiety and Depression: What Do We Know of Neuropeptides?

Authors:  Ida Kupcova; Lubos Danisovic; Ivan Grgac; Stefan Harsanyi
Journal:  Behav Sci (Basel)       Date:  2022-07-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.